Atypical Withdrawal Symptoms after Abrupt Tramadol Discontinuation: A Case Report.
Tramadol
atypical withdrawal
opioid taper
withdrawal symptoms
Journal
Journal of pain & palliative care pharmacotherapy
ISSN: 1536-0539
Titre abrégé: J Pain Palliat Care Pharmacother
Pays: England
ID NLM: 101125608
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
medline:
29
11
2023
pubmed:
4
10
2023
entrez:
4
10
2023
Statut:
ppublish
Résumé
Tramadol is a commonly utilized analgesic in the United States. One common misconception is that tramadol is safer than other opioid medications, or less likely to cause physical dependence. Given these misconceptions, the likelihood of patients experiencing withdrawal after discontinuation may be commonly overlooked as well. A 68-year old female patient with fibromyalgia was referred to a clinical pharmacy pain clinic for medication management. The patient was evaluated one month after abrupt discontinuation of tramadol 50 mg every 6 h for at least 10 years of use. She reports concerning symptoms of significant mucus production, fullness in chest and soreness in neck. Although tramadol is a Schedule IV Controlled Substance the risk of physical dependence and likelihood of patients experiencing withdrawal symptoms after abrupt cessation should not be diminished. Tramadol should not be considered a "safer" opioid therapy without potential of classic or atypical withdrawal symptoms, as well as risk of abuse, misuse or addiction.
Identifiants
pubmed: 37791819
doi: 10.1080/15360288.2023.2261913
doi:
Substances chimiques
Tramadol
39J1LGJ30J
Analgesics, Opioid
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM